Open research questions in Genetics and Neurodevelopmental Disorders
88 unresolved questions extracted from the limitations and future-work sections of 402 Genetics and Neurodevelopmental Disorders papers in our library. Each links back to the study that raised it.
What the literature leaves open
One challenge is the development of effective treatments for fragile X syndrome. Another challenge is the need to understand the underlying mechanisms of FXS and its associated EEG abnormalities. The study also faced the challenge of assessing the effects of blarcamesine on EEG biomarkers in a mouse model of FXS.
Blarcamesine improves EEG biomarkers of cortical dysfunction in a mouse model of fragile X syndrome · 2026 · DOIFurther studies are needed to fully understand the effects of blarcamesine on EEG biomarkers in fragile X syndrome. Research on the optimal dosage and treatment duration of blarcamesine is required. Investigations into the mechanisms underlying blarcamesine's effects on EEG biomarkers are necessary.
Blarcamesine improves EEG biomarkers of cortical dysfunction in a mouse model of fragile X syndrome · 2026 · DOIU2OS is non-diploid and its karyotype is abnormal, - the study focused on a single experimental condition, - the link to RT advance and break formation is unclear in mid-late S-phase
Single-cell mapping of chromosome breaks identifies multiple fragile site classes with distinct DNA replication timing landscapes · 2026 · DOIinvestigating the link to RT advance and break formation, - analyzing other cell types to see if the findings are conserved, - exploring the mechanisms of breaks in non-CFS regions
Single-cell mapping of chromosome breaks identifies multiple fragile site classes with distinct DNA replication timing landscapes · 2026 · DOIWhile the MeCP2 methyl-CpG binding domain (MBD) is well-characterized, the function of the adjacent intervening domain (ID) remains largely understudied.
Here, we address these conflicting findings by demonstrating the MBD and ID do not function in isolation but as a synergistic functional unit.
RESULTS: variants across 45 families, identifying 25 variants that have not been previously reported.
Further longitudinal and naturalistic studies are warranted, along with the development of structured tools to assist clinicians in optimizing pharmacological care for this vulnerable population.
Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed review · 2025 · DOIThese findings highlight key limitations of the current literature, including the scarcity of studies focusing specifically on ID populations, small sample sizes, the limited number of RCTs, and often controversial or inconsistent results.
Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed review · 2025 · DOIDiscussion and conclusion This case contributes to the limited literature on ZMYM3-related NDDs in females, highlighting potential variability in phenotypic expression due to X-inactivation and penetrance effects.
The gender-sensitive spectrum of neurodevelopmental disorders: a case report on a ZMYM3 variant in a 19-year-old female · 2025 · DOIThe Zinc finger MYM-type protein 3, located on the X-chromosome, has been implicated in neurodevelopment, but its effects in females remain poorly understood due to limited research.
The gender-sensitive spectrum of neurodevelopmental disorders: a case report on a ZMYM3 variant in a 19-year-old female · 2025 · DOIThus, the GABBR1 variant may be a modifying factor in this case, though its pathogenicity remains uncertain.
Case Report: Diagnostic assessment, developmental trajectory and treatment approaches in a case of a complex neurodevelopmental syndrome associated with non- synonymous variants in MECP2 (p. R133C) and GABBR1 · 2025 · DOIFurther investigation of these phenotypes in CAKUT patients carrying ZMYM2 mutations will enhance our understanding of their phenotypes and improve strategies for early diagnosis, monitoring, and treatment.
Genitourinary defects, anxiety and aggressive-like behavior and glucose metabolism disorders in Zmym2 mutant mice with inserted piggyBac transposon · 2025 · DOIAfter 6-18 months of typical neurodevelopment, RTT girls undergo a poorly understood regression.
Sex-specific single cell-level transcriptomic signatures of Rett syndrome disease progression · 2024 · DOIHowever, little is known about the shared genetic mechanisms and causality behind such associations.
Unraveling shared susceptibility loci and Mendelian genetic associations linking educational attainment with multiple neuropsychiatric disorders · 2024 · DOIAfter the introduction of the Waldrop Scale, the studies conducted on MPAs in diseases with neurodevelopmental origin gave conflicting results.
25 years into research with the Méhes Scale, a comprehensive scale of modern dysmorphology · 2024 · DOI(Val837Met) variant and emphasizes the need for further research into effective therapeutic strategies for TRPM3-associated conditions.
Case Report: Expanded delineation of phenotype of TRPM3-related neurodevelopmental disorders · 2024 · DOIHowever, the precise mechanism by which D,L-methadone induces ER Ca2+ release remains to be defined.
PKA inhibition is a central step in D,L-methadone-induced ER Ca2+ release and subsequent apoptosis in acute lymphoblastic leukemia · 2024 · DOIThere is a need for accurate and consistent reporting of RYR1 variants. There is a need for guidelines for genetic testing, interpretation, and reporting of RYR1 variants.
EMQN Best Practice Guidelines for Genetic Testing and Reporting in RYR1-related disorders · 2026 · DOIFor quick reference, a summary of the major recommendations from this section, stratified by variants and clinical context is provided (box 1). Criteria for genetic testing of RYR1 Suspected clinical diagnosis of malignant hyperthermia. Patients who had features of a hypermetabolic reaction under general 4 Box 1 R.L. Robinson et al.
EMQN Best Practice Guidelines for Genetic Testing and Reporting in RYR1-related disorders · 2026 · DOIThe study identifies a gap in understanding the effects of Fmr1 deletion on adult-born dentate granule cells and glial populations. The study highlights the need to investigate the impact of early-life stress on FXS-related neuropathology.
Fmr1 Deletion and Early-Life Stress Interact to Increase Cell Proliferation and Glial Populations at the Expense of Immature Neurons in the Adult Dentate Gyrus · 2026 · DOIAbstract CC2D1A is a multidomain scaffold protein implicated in transcriptional regulation and autosomal recessive non-syndromic intellectual disability (NSID), yet its molecular mechanism is still poorly understood due to a lack of structural information.
Structural characterization of the human CC2D1A fragment associated with non-syndromic intellectual disability (NSID) · 2026 · DOIFurther studies are needed to investigate the role of KDM5B-mediated H3K4me3 demethylation in neurodevelopmental disorders. The development of therapeutic strategies targeting NMDAR signaling may be a potential approach for neurodevelopmental disorders associated with KDM5B deficiency.
Autism-like phenotypes and increased NMDAR2D expression in mice with KDM5B histone lysine demethylase deficiency · 2026 · DOIThe role of KDM5B-mediated H3K4me3 demethylation in neurodevelopmental disorders is not well understood. The mechanisms underlying the association between KDM5B loss-of-function variants and autism spectrum disorder (ASD) are not clear.
Autism-like phenotypes and increased NMDAR2D expression in mice with KDM5B histone lysine demethylase deficiency · 2026 · DOIThe relationship between FXS and cerebral aneurysms is not well understood. There is limited research on the causal link between FXS and cerebral aneurysms.
There is no Evidence that Fragile-X Syndrome Due to Low CGG Repeat Expansions in FMR1 Manifests Phenotypically with Cerebral Aneurysms · 2026 · DOI
Most-cited papers in Genetics and Neurodevelopmental Disorders
- Synaptic, transcriptional and chromatin genes disrupted in autism · Nature · 2014 · 2,651 citations
- The contribution of de novo coding mutations to autism spectrum disorder · Nature · 2014 · 2,457 citations
- From single to multiple deficit models of developmental disorders · Cognition · 2006 · 942 citations
- Advances in the Treatment of Fragile X Syndrome · PEDIATRICS · 2008 · 477 citations
- Generalist Genes and Learning Disabilities. · Psychological Bulletin · 2005 · 389 citations
- The tuberous sclerosis complex · Annals of the New York Academy of Sciences · 2009 · 345 citations
- Human Dysbindin (DTNBP1) Gene Expression inNormal Brain and in Schizophrenic Prefrontal Cortex and Midbrain · Archives of General Psychiatry · 2004 · 301 citations
- Human neural tube defects: Developmental biology, epidemiology, and genetics · Neurotoxicology and Teratology · 2005 · 288 citations
- Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism · Neurotoxicology and Teratology · 2000 · 285 citations
- Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder in Boys with the Fragile X Premutation · Journal of Developmental & Behavioral Pediatrics · 2006 · 274 citations
Most recent work
- Combined effects of Ret coding and enhancer loss-of-function alleles cause progressive loss of inhibitory motor neurons in the enteric nervous system · bioRxiv · 2026
- EMQN Best Practice Guidelines for Genetic Testing and Reporting in RYR1-related disorders · European Journal of Human Genetics · 2026
- Individualized antisense oligonucleotides for SCN2A-related developmental epileptic encephalopathy · Nature Medicine · 2026
- Clinical Clues to the Diagnostic Yield of Genetic Testing in Adults With Late-Onset Behavioral Change · Neurology Genetics · 2026
- Autism-like phenotypes and increased NMDAR2D expression in mice with KDM5B histone lysine demethylase deficiency · Science Advances · 2026
- A Researcher’s guide to rodent models of Down syndrome: Recent insights and translational perspectives · STAR Protocols · 2026
- Brain Mecp2 Gene Dosage and Gene Therapy Shape Multi-Omic Signatures and Putative Biomarkers in Rett Syndrome · bioRxiv · 2026
- Hypoplasticity in sensory-driven necortical circuits of Fragile X mice · bioRxiv · 2026
- ASXL3 truncating patient variants mediate transcriptional gain-of-function and are antisense oligonucleotide-responsive · medRxiv · 2026
- FNIP1 variants are associated with favourable metabolism in 1 million humans · Nature · 2026
Find a gap in your own Genetics and Neurodevelopmental Disorders sub-topic
This page shows what the Genetics and Neurodevelopmental Disorders literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →